Clinical-stage radiopharma pipeline of peptide-based, best-in-class oncology therapies
Cancer patients need more effective, targeted treatments that can improve outcomes while limiting damage to healthy tissue.
It develops peptide-based radiopharmaceutical oncology therapies that deliver targeted radiation to tumors.
Oncologists and hospitals/cancer centers treating patients with cancer.


